Glaucoma Surgical Devices Market Overview, Manufacturers, Types, Applications, Share, Growth Rate and Forecast 2025 to 2033

The 𝐠𝐥𝐚𝐮𝐜𝐨𝐦𝐚 𝐬𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 was valued at 𝐔𝐒𝐃 𝟕𝟒𝟐 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟒 and is projected to surpass 𝐔𝐒𝐃 𝟏,𝟓𝟒𝟔 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟑, growing at a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟖.𝟓% 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝 𝐨𝐟 𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟑. The rising prevalence of glaucoma worldwide, coupled with advancements in surgical technologies, underscores the critical need for effective glaucoma management solutions.

𝐓𝐡𝐞 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐨𝐟 𝐭𝐡𝐢𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:- https://www.astuteanalytica.com/request-sample/glaucoma-surgical-devices-market

𝐑𝐢𝐬𝐢𝐧𝐠 𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐮𝐫𝐝𝐞𝐧 𝐨𝐟 𝐆𝐥𝐚𝐮𝐜𝐨𝐦𝐚

In 2024, approximately 76 to 80 million people worldwide suffered from glaucoma, representing about 3-4% of the global population aged 40-80 years. This number is anticipated to increase significantly, reaching 111.8 million by 2040, driven by improved detection methods and aging populations. Glaucoma prevalence varies geographically, with northern African and Hispanic populations experiencing a higher burden due to primary open-angle glaucoma, impacting 3-5% of these groups. In contrast, prevalence in the Global North, including Europe and North America, is slightly lower, at 2-3%.

A major challenge in glaucoma management lies in its asymptomatic nature during the early stages, leading to underdiagnosis and delayed treatments. Such delays often complicate disease progression, making effective surgical interventions increasingly critical.

𝐒𝐮𝐫𝐠𝐞 𝐢𝐧 𝐆𝐥𝐚𝐮𝐜𝐨𝐦𝐚-𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐏𝐫𝐨𝐜𝐞𝐝𝐮𝐫𝐞𝐬

Each year, an estimated 1.5 to 2 million glaucoma-related surgeries are performed globally, with an annual growth rate of 5-7%. Developed countries account for a substantial share, performing 200-300 procedures per million individuals, while developing nations are witnessing rapid growth in surgical volumes due to improved healthcare access. Key surgical techniques include trabeculectomy (50-60%), micro-invasive glaucoma surgeries (MIGS) (20-30%), and implant drainage procedures (10-15%). Selective Laser Trabeculoplasty (SLT), used in 500,000-700,000 procedures annually, is another effective intervention.

The demand for glaucoma surgical devices is fueled by their enhanced safety and efficacy. The adoption of innovative solutions like MIGS is revolutionizing the landscape of glaucoma management.

𝐒𝐞𝐜𝐮𝐫𝐞 𝐘𝐨𝐮𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭:- https://www.astuteanalytica.com/industry-report/glaucoma-surgical-devices-market

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐆𝐫𝐨𝐰𝐭𝐡

𝟏. 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐆𝐞𝐫𝐢𝐚𝐭𝐫𝐢𝐜 𝐏𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧

The rising elderly population significantly contributes to the demand for glaucoma surgical devices. With the global population aged over 60 projected to reach 1.4 billion, the number of high-risk glaucoma patients is escalating. In the United States, glaucoma diagnoses are increasing, particularly among individuals over 65 years, highlighting the growing need for effective surgical solutions. Advanced devices like implants, drainage tubes, and micro-stents are essential for maintaining stable intraocular pressure (IOP) in such cases.

𝟐. 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐌𝐈𝐆𝐒

The trend toward minimally invasive glaucoma surgeries (MIGS) has transformed the glaucoma surgical devices market. Innovations such as iStent, Hydrus Microstent, XEN Gel Stent, and advanced implant materials have gained traction. In particular, micro-stent devices, designed to improve IOP without significant tissue damage, have seen widespread adoption, with over 200,000 units utilized globally in the past year alone.

𝟑. 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐢𝐧 𝐒𝐩𝐞𝐜𝐢𝐚𝐥𝐢𝐬𝐭 𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐢𝐥𝐢𝐭𝐲

Despite technological progress, the market faces a shortage of trained ophthalmologists, particularly in rural and underserved areas. Over 50% of glaucoma patients remain undiagnosed, delaying treatment and exacerbating disease progression. This disparity is particularly pronounced in developing regions, where access to advanced surgical devices and trained professionals remains limited.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐆𝐥𝐚𝐮𝐜𝐨𝐦𝐚 𝐒𝐮𝐫𝐠𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭

• AbbVie Inc. (Allergan Plc.)
• Alcon Inc
• Altomed
• ASICO, LLC
• Carl Zeiss Meditec AG
• Glaukos Corporation
• Iridex Corporation.
• iStar Medical SA
• Johnson & Johnson Vision
• Katalyst Surgical
• Lumenis Ltd
• New World Medical, Inc.
• Santen Pharmaceutical Co. Ltd
• Topcon Corporation
• Ziemer Ophthalmic Systems AG
• Other Prominent Players

𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:

𝐁𝐲 𝐃𝐞𝐯𝐢𝐜𝐞

• Canal Surgery Devices and Stents
• Tube Shunts

𝐁𝐲 𝐒𝐮𝐫𝐠𝐞𝐫𝐲 𝐓𝐲𝐩𝐞

• Trabeculectomy
• Glaucoma Drainage Implants
• Minimally Invasive Glaucoma Surgery (MIGS)
• Laser Surgeries
• Others

𝐁𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫𝐬

• Hospitals
• Ambulatory Surgical Systems
• Speciality Clinics

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA
• South America
• Argentina
• Brazil
• Rest of South America

𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:- https://www.astuteanalytica.com/request-sample/glaucoma-surgical-devices-market

𝐀𝐛𝐨𝐮𝐭 𝐀𝐬𝐭𝐮𝐭𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.

𝐆𝐞𝐭 𝐢𝐧 𝐭𝐨𝐮𝐜𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬

𝐏𝐡𝐨𝐧𝐞 𝐧𝐮𝐦𝐛𝐞𝐫: +18884296757
𝐄𝐦𝐚𝐢𝐥: sales@astuteanalytica.com
𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐰𝐞𝐛𝐬𝐢𝐭𝐞: https://www.astuteanalytica.com/

This release was published on openPR.